Drug-induced Liver Injury in Pediatrics

Fernanda Monge-Urrea1, Ericka Montijo-Barrios

  • 1From the Division of Pediatric Gastroenterology and Nutrition, Instituto Nacional de Pediatría, Mexico City, Mexico.

Insights

Drug-induced liver injury (DILI) is a rare cause of pediatric liver disease, often linked to antibiotics and antiepileptics. Prompt drug withdrawal is key for managing DILI in children.

Area of Science:

  • Pediatric Hepatology
  • Clinical Pharmacology
  • Drug Safety and Toxicology

Background:

  • Drug-induced liver injury (DILI) is an underdiagnosed cause of liver disease in children, accounting for approximately 10% of all DILI cases.
  • The exact incidence of DILI in the pediatric population remains unknown.
  • Commonly implicated hepatotoxic medications in children include antibiotics and antiepileptic drugs.

Purpose of the Study:

  • To review the characteristics, diagnosis, and management of drug-induced liver injury in pediatric patients.
  • To highlight the significance of DILI as a cause of liver disease in children.
  • To emphasize the importance of accurate causality assessment and prompt intervention.

Main Methods:

  • Review of existing literature and case reports on pediatric DILI.
  • Discussion of DILI classification (intrinsic vs. idiosyncratic) and injury patterns (hepatocellular vs. cholestatic).
  • Application of the Roussel Uclaf Causality Assessment Method (RUCAM) for diagnosis.

Main Results:

  • DILI presents primarily with hepatocellular or cholestatic injury patterns in children.
  • Antibiotics and antiepileptics are the most frequent culprits.
  • The Roussel Uclaf Causality Assessment Method (RUCAM) aids in diagnosing DILI.

Conclusions:

  • Drug-induced liver injury is a critical consideration in pediatric liver disease.
  • Early identification and withdrawal of the offending agent are paramount for successful treatment.
  • Further research is needed to establish the precise incidence and risk factors for DILI in children.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.3K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
308
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
239
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
538
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
212